The endometrium is a complex steroid-responsive tissue that undergoes cyclic proliferation, hypertrophy, and differentiation in anticipation of embryo implantation. In the human, when pregnancy does not occur, menstrual shedding is followed by healing and intense proliferation in response to circulating estrogen resulting from ovarian follicular development. After ovulation, progesterone is secreted from the newly formed corpus luteum, transforming the endometrium into a secretory structure and establishing receptivity toward the nascent embryo, precisely and synchronously timed around a window of implantation [1] . Delays in the developmental milestones of the endometrium [2] can lead to infertility or pregnancy loss. Moreover, imbalance between the actions of estrogen and progesterone are associated with abnormal uterine bleeding [3] and proliferative disorders, such as endometriosis and endometrial hyperplasia [4] . Progesterone is essential for the establishment of pregnancy [5] , opposing the actions of estrogen by a remarkable number of different mechanisms. One recognized antiestrogenic action of progesterone in the endometrium is the regulation of the cognate receptors for estrogen and progesterone [6] . Although estrogen increases the concentration of its own receptor (ESR1) and that of progesterone (PGR), progesterone downregulates the availability of ESR1 in most endometrial cell types and reduces its own receptor in the glandular epithelium. The reduction in steroid receptors is one of many means by which progesterone limits the action of estrogen during the secretory phase of the normal menstrual cycle.
MicroRNAs and Their Role in Regulation of Gene Expression
MicroRNAs are small nonprotein coding RNAs that regulate specific posttranscriptional mRNAs targeting them for degradation. Genes coding for miRNA represent 1% to 4% of the genes in higher organisms and are highly processed sequences that are derived from larger RNA transcripts. These small precursor miRNAs of 70 to 90 nucleotides are transported to the cytoplasm, where they undergo cleavage by the RNAse III enzyme, Dicer, to generate a double-stranded miRNA duplex, eventually forming a single-stranded miRNA that binds to complementary sequences on target mRNA and preventing their transcription [7] [8] [9] . This extraordinarily complex regulatory mechanism of transcription was first recognized in 1993 [10] , and the characterization of miRNAs in the endometrium followed in the last few years [11] [12] [13] [14] . These highly conserved sequences appear to provide a vital regulatory control on gene expression by silencing the transcription of existing mRNAs. In tissues such as the endometrium where rapidly changing steroid hormone signaling occurs, with well-demarcated stages of development [15] , it may not be surprising that miRNAs maintain a role in gene regulation (Fig. 1) .
Using genomic profiling, Kuokkanen et al. [16] report on a further characterization of this process in human endometrium. They isolated glandular epithelial cells from the proliferative and midsecretory phases, corresponding to times of peak estrogen and progesterone action during the menstrual cycle, and demonstrated inverse relationships between the suppression of certain genes involved in cell cycling and the expression of specific miRNAs. Late proliferative and midsecretory endometrial samples were obtained by biopsy from young, fertile, healthy, regularly cycling volunteers. These well-characterized samples were subjected to validated cell separation methodology to collect highly purified fractions of glandular epithelium, which were subjected to RNA extraction and microarray analysis. MicroRNA profiling studies on miRNA-enriched RNA samples was also performed and compared to the microarray analyses using mRNA, validating their results using real-time quantitative RT-PCR.
This study provides a detailed look at the relationships between mRNA and miRNA expression during two different phases of the menstrual cycle. The first estrogen-dominant phase is characterized by cell proliferation, whereas the second represents the interval corresponding to maximal endometrial receptivity and peak progesterone action, where cell cycling is curtailed. The authors identify and confirm previous reports showing that hundreds of genes are differentially expressed in these two different phases of the menstrual cycle, reflecting the functional characteristics of each phase. Like the patterns of mRNA expression, the changes in miRNA accurately identified the samples based on expression differences alone, using unsupervised hierarchical clustering analysis, with each phase exhibiting unique patterns of both mRNA and miRNA expression. Of note, the authors demonstrate that specific cell cycle genes are targeted by miRNA in the midsecretory phase, effectively lowering the transcription of those genes, among others, at a time when cell cycling is normally turned off.
Implications for Endometrial Health and Disease
The increasing attention to miRNAs and their role in health and disease comes at an exciting time for endometrial research. Studies past and present have shown that the regulation of estrogen action by progesterone is multidimensional. The importance of progesterone dominance over estrogen in the secretory phase is illustrated by the nearly universal finding of downregulation of ESR1 at the time of implantation in studied mammalian species [4] . Progesterone action on the endometrium induces enzymes that metabolize estradiol and reduce its effective concentration [17] . Progesterone modulates signaling pathways that estrogen uses for cell proliferation and cell cycling, including induction of Dickkopf (DKK1), a protein that blocks the receptor for WNT7A (frizzled) required for inactivation of glycogen synthase kinase 3-beta (GSK3B), which normally blocks the accumulation of beta-catenin and cellular proliferation [18] . Progesterone induces transcription factors that regulate key proapoptotic and cell cycle pathways, including FOXO1 [19, 20] , epidermal growth factor (EGF) antagonists like Mig-6 (ERRFI1) [21] , and Coup-TFII (NR2F2), which signals through paracrine mechanisms to block the proliferative effects of estrogen [22] . The paper by Kuokkanen et al. [16] strongly suggests that progesterone acts to oppose estrogen by yet another mechanism, inducing expression of miRNAs to fine tune expression of endometrial genes.
In many diseases affecting the endometrium, excessive estrogen-mediated proliferation appears to play a major role. A loss of the normal balance between the actions of estrogen and progesterone is evidenced in polycystic ovary syndrome, endometriosis, and endometrial neoplastic diseases [1] . In recent years, there have been compelling data that suggest a biochemical resistance to progesterone in the endometrium of some women contributes to pregnancy loss, infertility, and endometrial hyperplasia or cancer [4, 23] . The study by Kuokkanen and coworkers suggests that miRNAs are a logical next place to look for evidence of a mechanism for progesterone resistance. If normally progesterone-stimulated miRNAs are disrupted, expression from the mRNA targets of each miRNA may fail to be suppressed, allowing excessive cell proliferation. In fact, recent work by others is already confirming the hypothesis that miRNAs are diagnostic smoking guns [13, [24] [25] [26] [27] [28] [29] . This is an area of intense investigation and one that is worth watching, especially for those interested in the endometrium, infertility, cancer, and even contraception.
FIG. 1.
Ovarian steroids regulate the endometrium through cognate receptors (ESR1 or PGR) in the epithelium and stroma. Under the actions of estrogen, directly or through paracrine mechanisms, the epithelial cells respond by rapid induction of gene expression that promotes DNA synthesis and cell replication. The actions of progesterone counter the effects of estrogen in the endometrium through paracrine regulators from the stroma, such as heparin binding-epidermal growth factor (HB-EGF), bone morphogenic protein (BMP), or insulin-like growth factor binding protein-1 (IGFPB1), or by direct action on the epithelial PGR. Among the many layers of control exerted by progesterone, the regulation of specific miRNAs is a mechanism that appears to fine tune gene expression, and in this case block cell proliferation at the time of implantation, under the control of progesterone.
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